# Chia‐Yu Chu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/chia-yu-chu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,131 |
| Field | Dermatology and Skin Diseases |
| h-index | 52 |
| i10-index | 160 |
| Last Known Institution | National Taiwan University |
| OpenAlex ID | https://openalex.org/A5062947819 |
| ORCID iD | 0000-0002-9370-3279 |
| Works | 383 |

## Researcher papers

Showing 12 of 15.

- [HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol](https://scholariq.org/papers/hla-b-5801-allele-as-a-genetic-marker-for-severe-cutaneous-adverse-reactions/)
- [Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study](https://scholariq.org/papers/drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-an-original/)
- [The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro](https://scholariq.org/papers/the-scfbeta-trcp-ubiquitin-ligase-complex-associates-specifically-with/)
- [Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials](https://scholariq.org/papers/once-daily-upadacitinib-versus-placebo-in-adolescents-and-adults-with-moderate/)
- [Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis](https://scholariq.org/papers/abrocitinib-versus-placebo-or-dupilumab-for-atopic-dermatitis/)
- [Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction](https://scholariq.org/papers/tumor-associated-macrophage-induced-invasion-and-angiogenesis-of-human-basal/)
- [Drug Reaction With Eosinophilia and Systemic Symptoms](https://scholariq.org/papers/drug-reaction-with-eosinophilia-and-systemic-symptoms/)
- [Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/two-phase-3-trials-of-lebrikizumab-for-moderate-to-severe-atopic-dermatitis/)
- [Common Risk Allele in Aromatic Antiepileptic-Drug Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Han Chinese](https://scholariq.org/papers/common-risk-allele-in-aromatic-antiepileptic-drug-induced-stevens-johnson/)
- [Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System](https://scholariq.org/papers/drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-an-interplay-among/)
- [Impact of Atopic Dermatitis on Work and Activity Impairment in Taiwan](https://scholariq.org/papers/impact-of-atopic-dermatitis-on-work-and-activity-impairment-in-taiwan/)
- [Economic Burden of Atopic Dermatitis in Taiwan](https://scholariq.org/papers/economic-burden-of-atopic-dermatitis-in-taiwan/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Drug-Induced Adverse Reactions](https://scholariq.org/topics/drug-induced-adverse-reactions/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)

## Researcher university

- [National Taiwan University](https://scholariq.org/institutions/national-taiwan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.